Brief: Biovaxys Technology Files FDA Pre-Ind Meeting Request And Briefing Package For Covid-T
31/03/2021 13:12
March 31 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS FILES FDA PRE-IND MEETING REQUEST AND BRIEFING
PACKAGE
FOR COVID-T
Source text for Eikon: ID:nCNWSDjg0a
Further company coverage: BIOV.CD
((reuters.briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000